Clinical Trials Directory

Trials / Completed

CompletedNCT01184014

Hospital Insulin Protocol Aims for Glucose Control in Corticosteroid-induced Hyperglycemia

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
72 (actual)
Sponsor
HealthPartners Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to determine the best insulin regimen for hospitalized patients who receive high doses of steroids who have high blood glucose.

Detailed description

The overall study objective of this research is to establish the efficacy and assure the safety of achieving glycemic control in hospitalized patients who receive greater than physiologic doses of steroids. This study will compare 2 methods of achieving glycemic control in hospitalized patients who develop steroid-induced hyperglycemia (blood glucose (BG) \>180 mg/dL): 1) a study-specific steroid NPH dosing algorithm plus standard recommended care (Experimental group) vs. 2) the standard recommended care (Methodist Hospital Complete Insulin Orders (Control group).

Conditions

Interventions

TypeNameDescription
DRUGNPH insulin plus Complete Insulin OrdersNPH dosed per study-specific algorithm which incorporates total daily dosage of steroid to determine NPH dose. Complete insulin orders include background, meal-time and correction factor.
DRUGComplete Insulin Orders3-part insulin which includes background, meal-time and correction factor

Timeline

Start date
2010-08-01
Primary completion
2012-08-01
Completion
2012-08-01
First posted
2010-08-18
Last updated
2018-06-13
Results posted
2013-11-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01184014. Inclusion in this directory is not an endorsement.